Live Quote · NASDAQTEMHealthcare · Medical - Healthcare Information Services

Tempus AI, Inc.

$60.27▼ 2.16%($-1.33)

TickerSpark Score

58/100

▌ Mixed

33

Valuation

40

Profitability

100

Growth

68

Health

50

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TEM research report →

52-Week Range30% of range

Low

$41.73

Current

$60.27

High

$104.32

Company Overviewwww.tempus.com

About the company

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.

CEO: Eric Lefkofsky
IPO: 2024
Employees: 3,800
HQ: Chicago, IL, US

Price Chart

+1.84% · this period

Valuation

Market Cap: $10.52B
P/E: -35.25
P/S: 7.71
P/B: 25.89
EV/EBITDA: -83.44
Div Yield: 0.00%

Profitability

Gross Margin: 69.55%
Op Margin: -18.13%
Net Margin: -22.20%
ROE: -70.24%
ROIC: -13.27%

Growth & Income

Revenue: $1.27B · 83.41%
Net Income: $-245,028,000 · 65.28%
EPS: $-1.41 · 69.35%
Op Income: $-238,635,000
FCF YoY: -13.25%

Performance & Tape

52W High: $104.32
52W Low: $41.73
50D MA: $50.66
200D MA: $63.08
Beta: 3.46
Avg Volume: 6.61M

Get TickerSpark's AI analysis on TEM

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

Date	Insider	Role	Type	Shares	Value
Jun 29, 26	LEFKOFSKY ERIC P	director, 10 percent owner, officer: CEO and Chairman	sell	9,271	$513.43K
Jun 29, 26	LEFKOFSKY ERIC P	director, 10 percent owner, officer: CEO and Chairman	sell	37,711	$2.13M
Jun 29, 26	LEFKOFSKY ERIC P	director, 10 percent owner, officer: CEO and Chairman	sell	41,178	$2.35M
Jun 29, 26	LEFKOFSKY ERIC P	director, 10 percent owner, officer: CEO and Chairman	sell	8,320	$485.06K
Jun 29, 26	LEFKOFSKY ERIC P	director, 10 percent owner, officer: CEO and Chairman	sell	36,520	$2.16M
Jun 29, 26	LEFKOFSKY ERIC P	director, 10 percent owner, officer: CEO and Chairman	sell	2,317	$128.32K
Jun 29, 26	LEFKOFSKY ERIC P	director, 10 percent owner, officer: CEO and Chairman	sell	9,430	$532.89K
Jun 29, 26	LEFKOFSKY ERIC P	director, 10 percent owner, officer: CEO and Chairman	sell	10,293	$588.04K
Jun 29, 26	LEFKOFSKY ERIC P	director, 10 percent owner, officer: CEO and Chairman	sell	2,080	$121.26K
Jun 29, 26	LEFKOFSKY ERIC P	director, 10 percent owner, officer: CEO and Chairman	sell	9,130	$540.77K

Coverage · TEM

Our TEM coverage

Recent articles, reports, and earnings notes.

View all →

Top Stocks

AI Biotech Stocks That Show Real Revenue: 7 Picks Worth Watching

These seven AI biotech stocks span diagnostics, software, platform discovery, and commercial therapeutics, ranked by investment quality for June 2026.